|
|
|
|
Mycosis Fungoides
Do unsaturated fatty acids function as endogenous antibacterial ... Feb 14, 2006
Am J Clin Nutr (subscription), ...within minutes of contact (7). The oral administration of LA as safflower oil (which contains 76% LA) produced the remission of mycosis fungoides, a rare skin ...
Genmab Announces Responses With HuMax-CD4(TM) in Non-Cutaneous T ... Dec 12, 2005
Yahoo! News (press release) The most common types of CTCL include mycosis fungoides (MF) and Sezary syndrome (SS). CTCL result from transformation of T-lymphocytes into malignant cells. ...
Seattle Genetics Reports on SGN-30 Clinical Program at the ... Dec 12, 2005
Genetic Engineering News, The study was recently amended to include two other related CD30-positive indications: transformed mycosis fungoides and lymphomatoid papulosis (LyP). ...
Mycosis Fungoides Aug 27, 2005
Mycosis fungoides is the most common of the cutaneous T-cell lymphomas, a group of rare cancers that grow in the skin. Sezary syndrome ... rarediseases.about.com
Allogeneic Stem Cell Transplants Effective for Refractory ... Sep 6, 2005
Mycosis fungoides and Sezary syndrome are cutaneous T-cell lymphomas. ... Mycosis fungoides can also evolve to a tumor stage with involvement of lymph nodes. ... Cancer Consultants (press release),
Serono and Genmab Announce Global Development and ... Aug 17, 2005
...rashes, plaques and tumors. The most common types of CTCL include mycosis fungoides (MF) and Sezary syndrome (SS). CTCL result from ... Yahoo News (press release)
Mycosis Fungoides -- Aug 27, 2005
Mycosis fungoides is the most common of the cutaneous T-cell lymphomas, a group of rare cancers that grow in the skin. Sezary syndrome ... / rarediseases.about.com
Allogeneic Stem Cell Transplants Effective for Refractory ... -- Sep 6, 2005
Mycosis fungoides and Sezary syndrome are cutaneous T-cell lymphomas. ... Mycosis fungoides can also evolve to a tumor stage with involvement of lymph nodes. ... / Cancer Consultants (press release),
Serono and Genmab Announce Global Development and ... -- Aug 17, 2005
...rashes, plaques and tumors. The most common types of CTCL include mycosis fungoides (MF) and Sezary syndrome (SS). CTCL result from ... / Yahoo News (press release)
Mycosis Fungoides Aug 27, 2005
Mycosis fungoides is the most common of the cutaneous T-cell lymphomas, a group of rare cancers that grow in the skin. Sezary syndrome ... rarediseases.about.com
Allogeneic Stem Cell Transplants Effective for Refractory ... Sep 6, 2005
Mycosis fungoides and Sezary syndrome are cutaneous T-cell lymphomas. ... Mycosis fungoides can also evolve to a tumor stage with involvement of lymph nodes. ... Cancer Consultants (press release),
Serono and Genmab Announce Global Development and ... Aug 17, 2005
...rashes, plaques and tumors. The most common types of CTCL include mycosis fungoides (MF) and Sezary syndrome (SS). CTCL result from ... Yahoo News (press release)
Mycosis Fungoides -- Jun 10, 2005
Mycosis fungoides is the most common of the cutaneous T-cell lymphomas, a group of rare skin cancers. Sezary syndrome, a more rare ... / rarediseases.about.com
Intensive Therapy No Better Than CHOP for T-Cell Non-Hodgkin ... -- Jun 7, 2005
Dr. Dang's group therefore reviewed records of patients with non-mycosis fungoides T-NHL treated at their institution between 1996 and 2002, to evaluate ... / Cancerpage.com,
Books, Journals, New Media Received -- Mar 15, 2005
Alopecia Mucinosa Is Mycosis Fungoides: Contrary View on Behalf of Patients by Almut Böer and A. Bernard Ackerman, 94 pp, with illus, paper, $20, ISBN 1-893357 ... / Journal of American Medical Association (subscription),
HuMax-CD4(TM) Continues to Show Long Lasting Responses in T-Cell ... -- Feb 18, 2005
...today additional encouraging duration of response data from one of its HuMax-CD4 (zanolimumab) Phase II studies treating patients with mycosis fungoides (MF) a ... / PR Newswire (press release)
Genmab antibody shows lasting responses in skin cancer -- Feb 21, 2005
...has reported additional encouraging duration of response data from one of its HuMax-CD4 phase II studies treating patients with mycosis fungoides, a type of ... / Pharmaceutical Business Review
Gloucester Pharmaceuticals Initiates Pivotal Trial with FK228 in ... -- Mar 1, 2005
CTCL is a group of diseases, including Mycosis Fungoides and Sezary syndrome, all constituting types of non-Hodgkin's lymphoma in which certain cells of the ... / PharmaLive.com (press release),
Books, Journals, New Media Received Mar 15, 2005
Alopecia Mucinosa Is Mycosis Fungoides: Contrary View on Behalf of Patients by Almut Böer and A. Bernard Ackerman, 94 pp, with illus, paper, $20, ISBN 1-893357 ... Journal of American Medical Association (subscription)
HuMax-CD4(TM) Continues to Show Long Lasting Responses in T-Cell ... Feb 18, 2005
...today additional encouraging duration of response data from one of its HuMax-CD4 (zanolimumab) Phase II studies treating patients with mycosis fungoides (MF) a ... PR Newswire
Genmab antibody shows lasting responses in skin cancer Feb 21, 2005
...has reported additional encouraging duration of response data from one of its HuMax-CD4 phase II studies treating patients with mycosis fungoides, a type of ... Pharmaceutical Business Review
Gloucester Pharmaceuticals Initiates Pivotal Trial with FK228 in ... Mar 1, 2005
CTCL is a group of diseases, including Mycosis Fungoides and Sezary syndrome, all constituting types of non-Hodgkin's lymphoma in which certain cells of the ... PharmaLive.com
Genmab's HuMax-CD4 Receives EU Orphan Drug Designation May 25, 2004
...response. There was also a statistically significant dose response correlation in 38 early and late stage mycosis fungoides patients. ... PR Newswire
Boise restaurateur loses cancer fight May 10, 2004
...hockey ice. Neville, 60, died Wednesday after a long battle with mycosis fungoides, a T-cell lymphoma that affects the skin. He ... IdahoStatesman.com
Mycosis Fungoides -- Oct 10, 2004
Mycosis fungoides is the most common of the cutaneous T-cell lymphomas, a group of rare skin cancers. Sezary syndrome, a more rare ... / rarediseases.about.com
Genmab Announces Results for the First Nine Months of 2004 -- Nov 2, 2004
US FDA orphan drug designation of HuMax-CD4 for the treatment of Mycosis Fungoides (MF), which constitutes 75% of all cutaneous T-cell lymphomas (CTCL). ... / New Ratings
Gloucester Pharmaceuticals Receives Fast Track Designation for ... -- Oct 12, 2004
CTCL is a group of diseases, including Mycosis Fungoides and Sezary syndrome, all constituting types of non-Hodgkin's lymphoma in which certain cells of the ... / Business Wire (press release),
US Gives Genmab Drug Orphan Status For Mycosis Fungoides -- Aug 24, 2004
Genmab said the designation had been granted for the treatment of mycosis fungoides (MF), which accounts for some 75% of all cutaneous T-cell lymphomas (CTCL). ... / Cancerpage.com,
COMUNICADO DE GENMAB A/S -- Sep 1, 2004
This duration of response data is based on an analysis of responding mycosis fungoides (MF) patients at all dose levels, 280, 560 and 980 mg. ... / Europa Press,
T-Cell Lymphoma Patients Achieve Long Lasting Responses With ... -- Sep 1, 2004
This duration of response data is based on an analysis of responding mycosis fungoides (MF) patients at all dose levels, 280, 560 and 980 mg. ... / PR Newswire (press release)
Genmab's HuMax-CD4 receives US orphan drug designation -- Aug 23, 2004
Genmab has announced that HuMax-CD4 for the treatment of Mycosis Fungoides (MF), which constitutes 75% of all Cutaneous T-cell Lymphomas (CTCL), has been ... / News-Medical.net,
Genmab to Present HuMax-CD4 Phase II Duration of Response Data -- Aug 11, 2004
Thirty-eight CTCL patients with Mycosis Fungoides (MF) were treated in these studies and 42% achieved at least a partial response, 30% at the 280 mg dose, 50 ... / PR Newswire (press release)
COMUNICADO DE GENMAB A/S -- Aug 23, 2004
Genmab A/S (CSE: GEN) announced today that HuMax-CD4 for the treatment of Mycosis Fungoides (MF), which constitutes 75% of all Cutaneous T-cell Lymphomas (CTCL ... / Europa Press,
Browse News by Band Name -- Aug 19, 2004
Dennis "D-Roc" Miles, a guitarist in Ice-T's band Body Count, died Tuesday of mycosis fungoides, a cancer that attacks the lymph nodes and skin. ... / MTV
Another Death For Ice-T's Group Body Count -- Aug 18, 2004
Miles, a member of the group fronted by veteran rapper Ice-T, was suffering with mycosis fungoides, a disease that has no known cure. ... / AllHipHop
Genmab Initiates HuMax-CD4 Study in Non-Cutaneous T-cell Lymphoma -- Aug 13, 2004
T-cell lymphomas positive for the CD4 receptor constitute around 5% of Non-Hodgkin's Lymphomas. The most predominant type of CTCL is Mycosis Fungoides (MF). ... / Yahoo News (press release)
Genmab's HuMax-CD4 Receives US Orphan Drug Designation -- Aug 23, 2004
23 /PRNewswire-FirstCall/ -- Genmab A/S (CSE: GEN - News) announced today that HuMax-CD4 for the treatment of Mycosis Fungoides (MF), which constitutes 75% of ... / Yahoo News (press release)
Genmab Initiates HuMax-CD4 Study in Non-Cutaneous T-cell Lymphoma -- Aug 13, 2004
Lymphomas. The most predominant type of CTCL is Mycosis Fungoides (MF). The US prevalence of MF is estimated at 16,000 to 20,000. ... / PR Newswire (press release)
Genmab to Present HuMax-CD4 Phase II Duration of Response Data -- Aug 11, 2004
Thirty-eight CTCL patients with Mycosis Fungoides (MF) were treated in these studies and 42% achieved at least a partial response, 30% at the 280 mg dose, 50 ... / Yahoo News (press release) -
Genmab Announces 2004 First Half Year Results -- Aug 3, 2004
II data in HuMax-CD4 cutaneous T-cell lymphoma (CTCL) studies - 55% of higher dose patients treated for the primary indication, mycosis fungoides, achieved at ... / Yahoo News (press release) -
Classics in Clinical Dermatology With Biographical Sketches -- Jul 27, 2004
Bateman of molluscum contagiosum, papular urticaria, eczema, and sycosis barbae and by Jean-Louis Alibert of lupus vulgaris, keloid, and mycosis fungoides. ... / JAMA -
For Bristow, first cancer, next the Senior Olympics -- Jul 26, 2004
...avoid overheating. The Brentwood resident was diagnosed with mycosis fungoides, which affects his ability to sweat properly. Bristow ... / Contra Costa Times (subscription), CA -
|
|
|
